Guiling Wang
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
Papers in
-
- Nanoparticle-Based Drug Delivery 7
-
- Genomics and Chromatin Dynamics 5
- Genomics and Phylogenetic Studies 4
- Chromatin Remodeling and Cancer 3
- Co-authors
- Feng Li (6 shared papers)Xinze Cai (3 shared papers)Liu Cao (6 shared papers)Maosheng Cheng (2 shared papers)Zhi‐Feng Miao (5 shared papers)Ying Xie (8 shared papers)Funan Liu (1 shared paper)Wan-Liang Lü (7 shared papers)
- Journals
- Chinese Chemical Letters (5 papers)Oncotarget (3 papers)Cell Death and Disease (2 papers)Bioactive Materials (2 papers)Oncogene (2 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Guiling Wang
53 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 85
- Biomaterials 175
- Molecular Medicine 59
- Cancer Research 96
- Drug Discovery 2
- Oncology 139
Countries citing papers authored by Guiling Wang
This map shows the geographic impact of Guiling Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiling Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiling Wang more than expected).
Fields of papers citing papers by Guiling Wang
This network shows the impact of papers produced by Guiling Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiling Wang. The network helps show where Guiling Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Guiling Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 114 | |
| 2 | 2008 | 109 | |
| 3 | 2008 | 90 | |
| 4 | 2017 | 79 | |
| 5 | 2013 | 57 | |
| 6 | 2013 | 49 | |
| 7 | 2015 | 46 | |
| 8 | 2015 | 43 | |
| 9 | 2022 | 42 | |
| 10 | 2015 | 40 | |
| 11 | 2017 | 37 | |
| 12 | 2010 | 31 | |
| 13 | 2021 | 27 | |
| 14 | 2012 | 23 | |
| 15 | 2019 | 23 | |
| 16 | 2022 | 22 | |
| 17 | 2023 | 21 | |
| 18 | 2017 | 20 | |
| 19 | 2019 | 20 | |
| 20 | 2021 | 18 |
About Guiling Wang
Guiling Wang is a scholar working on Biomaterials, Molecular Biology, Physiology, Oncology and Genetics, having authored 56 papers that have together received 1.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), Luminescence and Fluorescent Materials (5 papers), Genomics and Chromatin Dynamics (5 papers), Genomics and Phylogenetic Studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Aquatic Invertebrate Ecology and Behavior (3 papers), Chromatin Remodeling and Cancer (3 papers) and Reproductive biology and impacts on aquatic species (3 papers). The work is most often cited by research in Biomaterials (175 citations), Molecular Medicine (59 citations), Cancer Research (96 citations), Drug Discovery (2 citations) and Oncology (139 citations). Guiling Wang has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Feng Li, Xinze Cai, Liu Cao, Maosheng Cheng, Zhi‐Feng Miao, Ying Xie, Funan Liu, Wan-Liang Lü, Huimian Xu and Shuai Meng. Their work appears in journals such as Chinese Chemical Letters, Oncotarget, Cell Death and Disease, Bioactive Materials and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.